Clinical Differences of EGFR Mutations in Exon 19 and 21 in Clinical Course of Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Jang, Tae Won [1 ]
Jung, Maanhong [1 ]
Oak, Chul H. [1 ]
Nam, Sung J. [1 ]
机构：
[1] Univ Med Coll, Pusan, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
lung cancer; Prognostic factors; Epidermal growth factor receptor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-020
引用
收藏
页码：S528 / S528
页数：1
相关论文
共 50 条
  • [1] The different clinical significance of EGFR mutations in exon 19 and 21 in non-small cell lung cancer patients of China
    Li, M.
    Zhang, Q.
    Liu, L.
    Liu, Z.
    Zhou, L.
    Wang, Z.
    Yue, S.
    Xiong, H.
    Feng, L.
    Lu, S.
    [J]. NEOPLASMA, 2011, 58 (01) : 74 - 81
  • [2] Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib
    Riely, GJ
    Pao, W
    Pham, DK
    Li, AR
    Rizvi, N
    Venkatraman, ES
    Zakowski, MF
    Kris, MG
    Ladanyi, M
    Miller, VA
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (03) : 839 - 844
  • [3] CLINICAL CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER WITH EGFR GENE MUTATIONS IN EXON 20
    Miyanaga, A.
    Akagi, K.
    Takeuchi, S.
    Kurimoto, F.
    Iijima, Y.
    Yoshino, N.
    Mikami, I.
    Akiyama, H.
    Sakai, H.
    [J]. LUNG CANCER, 2009, 64 : S54 - S54
  • [4] Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer
    Ying Jin
    Ming Chen
    Xinmin Yu
    [J]. Scientific Reports, 6
  • [5] Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer
    Jin, Ying
    Chen, Ming
    Yu, Xinmin
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [6] EGFR mutations in non-small cell lung cancer - Clinical implications
    Charpidou, Andriani
    Blatza, Despoina
    Anagnostou, Elsa
    Syrigos, Konstantinos N.
    [J]. IN VIVO, 2008, 22 (04): : 529 - 536
  • [7] The impact of EGFR exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancer
    Zhao, Chao
    Jiang, Tao
    Li, Jiayu
    Wang, Yan
    Su, Chunxia
    Chen, Xiaoxia
    Ren, Shengxiang
    Li, Xuefei
    Zhou, Caicun
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1149 - +
  • [8] Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
    Byeon, Seonggyu
    Kim, Youjin
    Lim, Sung Won
    Cho, Jang Ho
    Park, Sehoon
    Lee, Jiyun
    Sun, Jong-Mu
    Choi, Yoon-La
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    [J]. CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 623 - 631
  • [9] Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions
    Morita, Chie
    Yoshida, Tatsuya
    Shirasawa, Masayuki
    Masuda, Ken
    Matsumoto, Yuji
    Shinno, Yuki
    Yagishita, Shigehiro
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Motoi, Noriko
    Yatabe, Yasushi
    Ohe, Yuichiro
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions
    Chie Morita
    Tatsuya Yoshida
    Masayuki Shirasawa
    Ken Masuda
    Yuji Matsumoto
    Yuki Shinno
    Shigehiro Yagishita
    Yusuke Okuma
    Yasushi Goto
    Hidehito Horinouchi
    Noboru Yamamoto
    Noriko Motoi
    Yasushi Yatabe
    Yuichiro Ohe
    [J]. Scientific Reports, 11
12345